Product NDC: | 48102-008 |
Proprietary Name: | Erythromycin |
Non Proprietary Name: | Erythromycin |
Active Ingredient(s): | 5 mg/g & nbsp; Erythromycin |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 48102-008 |
Labeler Name: | Fera Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA062447 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100118 |
Package NDC: | 48102-008-39 |
Package Description: | 24 TUBE in 1 CARTON (48102-008-39) > 3.5 g in 1 TUBE |
NDC Code | 48102-008-39 |
Proprietary Name | Erythromycin |
Package Description | 24 TUBE in 1 CARTON (48102-008-39) > 3.5 g in 1 TUBE |
Product NDC | 48102-008 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythromycin |
Dosage Form Name | OINTMENT |
Route Name | OPHTHALMIC |
Start Marketing Date | 20100118 |
Marketing Category Name | ANDA |
Labeler Name | Fera Pharmaceuticals |
Substance Name | ERYTHROMYCIN |
Strength Number | 5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |